Search Results - "Doss, Deborah"

Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review) by Harris, Randall E, Beebe-Donk, Joanne, Doss, Hani, Burr Doss, Deborah

“…We comprehensively reviewed the published scientific literature on non-steroidal anti-inflammatory drugs (NSAIDs) and cancer and evaluated results based upon…”
Get more information

Single-Agent Bortezomib in Previously Untreated Multiple Myeloma: Efficacy, Characterization of Peripheral Neuropathy, and Molecular Correlations With Response and Neuropathy by RICHARDSON, Paul G, WANLING XIE, KESARI, Santosh, BRIEMBERG, Hannah R, SCHLOSSMAN, Robert L, MUNSHI, Nikhil C, THOMPSON HEFFNER, L, DOSS, Deborah, ESSELTINE, Dixie-Lee, WELLER, Edie, ANDERSON, Kenneth C, AMATO, Anthony A, MITSIADES, Constantine, CHANAN-KHAN, AsherA, LONIAL, Sagar, HASSOUN, Hani, AVIGAN, David E, OAKLANDER, Anne Louise, KUTER, David J, WEN, Patrick Y

“…PURPOSE To assess efficacy and safety of single-agent bortezomib in previously untreated patients with multiple myeloma, investigate prevalence of baseline and…”
Get full text

Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma by RICHARDSON, Paul G, WELLER, Edie, WARREN, Diane L, LUNDE, Laura E, MCKENNEY, Mary, DELANEY, Carol, MITSIADES, Constantine S, HIDESHIMA, Teru, DALTON, William, KNIGHT, Robert, ESSELTINE, Dixie-Lee, ANDERSON, Kenneth C, JAGANNATH, Sundar, AVIGAN, David E, ALSINA, Melissa, SCHLOSSMAN, Robert L, MAZUMDER, Amitabha, MUNSHI, Nikhil C, GHOBRIAL, Irene M, DOSS, Deborah

“…Lenalidomide and bortezomib are active in relapsed and relapsed/refractory multiple myeloma (MM). In preclinical studies, lenalidomide sensitized MM cells to…”
Get full text

Advances in oral therapy in the treatment of multiple myeloma by Doss, Deborah S

“…Conventional IV chemotherapy regimens used for induction chemotherapy or salvage therapy in the treatment of multiple myeloma (MM) are cumbersome, with a…”
Get full text

Expanding Role of Bortezomib in Multiple Myeloma: Nursing Implications by Colson, Kathleen, Doss, Deborah S, Swift, Regina, Tariman, Joseph

“…Multiple myeloma is the second most common hematologic malignancy and remains incurable, despite advances in chemotherapy and stem cell transplantation…”
Get full text

Bortezomib, a newly approved proteasome inhibitor for the treatment of multiple myeloma: nursing implications by Colson, Kathleen, Doss, Deborah S, Swift, Regina, Tariman, Joseph, Thomas, Teri E

“…Multiple myeloma (MM), a malignancy of the plasma cells, accounts for an estimated 14% of all newly diagnosed hematologic malignancies. Advances in…”
Get full text

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma by Richardson, Paul G., Weller, Edie, Lonial, Sagar, Jakubowiak, Andrzej J., Jagannath, Sundar, Raje, Noopur S., Avigan, David E., Xie, Wanling, Ghobrial, Irene M., Schlossman, Robert L., Mazumder, Amitabha, Munshi, Nikhil C., Vesole, David H., Joyce, Robin, Kaufman, Jonathan L., Doss, Deborah, Warren, Diane L., Lunde, Laura E., Kaster, Sarah, DeLaney, Carol, Hideshima, Teru, Mitsiades, Constantine S., Knight, Robert, Esseltine, Dixie-Lee, Anderson, Kenneth C.

“…This phase 1/2 study is the first prospective evaluation of lenalidomide-bortezomib-dexamethasone in front-line myeloma. Patients (N = 66) received 3-week…”
Get full text

A Qualitative Study of Reciprocal Teaching Instructional Model: Fostering Reading Comprehension in Preschool Children by Ferguson-Doss, Deborah

“…Reciprocal Teaching strategies implemented in elementary, middle school, high school, and college have been studied; however, there are no research studies to…”
Get full text

Phase 1 study of pomalidomide MTD, safety, and efficacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomib by Richardson, Paul G., Siegel, David, Baz, Rachid, Kelley, Susan L., Munshi, Nikhil C., Laubach, Jacob, Sullivan, Daniel, Alsina, Melissa, Schlossman, Robert, Ghobrial, Irene M., Doss, Deborah, Loughney, Nora, McBride, Laura, Bilotti, Elizabeth, Anand, Palka, Nardelli, Lisa, Wear, Sandra, Larkins, Gail, Chen, Min, Zaki, Mohamad H., Jacques, Christian, Anderson, Kenneth C.

“…This phase 1 dose-escalation study determined the maximum tolerated dose (MTD) of oral pomalidomide (4 dose levels) administered on days 1 to 21 of each 28-day…”
Get full text

A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma by Richardson, Paul G., Blood, Emily, Mitsiades, Constantine S., Jagannath, Sundar, Zeldenrust, Steven R., Alsina, Melissa, Schlossman, Robert L., Rajkumar, S. Vincent, Desikan, K. Raman, Hideshima, Teru, Munshi, Nikhil C., Kelly-Colson, Kathleen, Doss, Deborah, McKenney, Mary L., Gorelik, Svetlana, Warren, Diane, Freeman, Andrea, Rich, Rebecca, Wu, Anfang, Olesnyckyj, Marta, Wride, Kenton, Dalton, William S., Zeldis, Jerome, Knight, Robert, Weller, Edie, Anderson, Kenneth C.

“…This multicenter, open-label, randomized phase 2 study evaluated 2 dose regimens of lenalidomide for relapsed, refractory myeloma. Seventy patients were…”
Get full text

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma by Richardson, Paul G., Schlossman, Robert L., Weller, Edie, Hideshima, Teru, Mitsiades, Constantine, Davies, Faith, LeBlanc, Richard, Catley, Laurence P., Doss, Deborah, Kelly, Kathleen, McKenney, Mary, Mechlowicz, Julie, Freeman, Andrea, Deocampo, Reggie, Rich, Rebecca, Ryoo, Joan J., Chauhan, Dharminder, Balinski, Kathe, Zeldis, Jerome, Anderson, Kenneth C.

“…Thalidomide (Thal) can overcome drug resistance in multiple myeloma (MM) but is associated with somnolence, constipation, and neuropathy. In previous in vitro…”
Get full text

Renal, GI, and Peripheral Nerves: Evidence-Based Recommendations for the Management of Symptoms and Care for Patients With Multiple Myeloma by Faiman, Beth, Doss, Deborah, Colson, Kathleen, Mangan, Patricia, King, Tracy, Tariman, Joseph, Board
, and

Get full text

“This Must Be Worked Out Locally”: Race, Education, and Leadership in Rockingham County, North Carolina, 1820-1970 by Russell, Deborah Doss

“…Focusing on local leadership, this work is a close study of race and education in Rockingham County, North Carolina, from 1820 to 1970. The long history of…”
Get full text

Renal, GI, and Peripheral Nerves: Evidence-Based Recommendations for the Management of Symptoms and Care for Patients With Multiple Myeloma by Faiman, Beth, Doss, Deborah, Colson, Kathleen, Mangan, Patricia, King, Tracy, Tariman, Joseph D

“…A majority of patients with multiple myeloma experience damage to the kidneys and peripheral nerves either at diagnosis or throughout the disease. Symptoms of…”
Get full text

T-cell–depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect by Alyea, Edwin, Weller, Edie, Schlossman, Robert, Canning, Christine, Webb, Iain, Doss, Deborah, Mauch, Peter, Marcus, Karen, Fisher, David, Freeman, Andrea, Parikh, Bijal, Gribben, John, Soiffer, Robert, Ritz, Jerome, Anderson, Kenneth

“…Previous trials of allogeneic bone marrow transplantation (BMT) in patients with multiple myeloma (MM) have demonstrated high response rates but also high…”
Get full text

Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: results of an open-label multicenter phase 2 study of efficacy, toxicity, and biological activity by Richardson, Paul, Schlossman, Robert, Jagannath, Sundar, Alsina, Melissa, Desikan, Raman, Blood, Emily, Weller, Edie, Mitsiades, Constantine, Hideshima, Teru, Davies, Faith, Doss, Deborah, Freeman, Andrea, Bosch, Joan, Patin, John, Knight, Robert, Zeldis, Jerome, Dalton, William, Anderson, Kenneth

“…To determine the progression-free survival at 12 weeks, to evaluate the toxic effects, and to analyze the biological activity of thalidomide in patients with…”
Get more information

The Impact of Reading Interventions on the Academic Achievement of Middle School Students by Doss, Deborah Leigh

“…The purpose of this study was to explore the impact of reading intervention at the middle school level with students who are performing below grade level. The…”
Get full text

Lack of health maintenance examinations and risk in myeloma patients by Tariman, Joseph D., Gleason, Charise, Faiman, Beth, Doss, Deborah, Catamero, Donna, Bishop‐Royse, Jessica, Katz, Mike, Kurtin, Sandra, Moran, Diane, Lonial, Sagar

“…Health maintenance (HM) practices are essential to prevent illness, promote well‐being, and maximize health. Patients with multiple myeloma (MM) are at…”
Get full text

Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies by TREON, Steven P, MITSIADES, Constantine, MITSIADES, Nicholas, YOUNG, Gloria, DOSS, Deborah, SCHLOSSMAN, Robert, ANDERSON, Kenneth C

“…The anti-CD20 chimeric monoclonal antibody rituximab (Rituxan) is used to treat patients with various B-cell tumors, including patients with plasma cell…”
Get full text

Thromboembolic events associated with novel therapies in patients with multiple myeloma: consensus statement of the IMF Nurse Leadership Board by Rome, Sandra, Doss, Deborah, Miller, Kena, Westphal, Jeanne

“…Patients with myeloma are at risk for serious and life-threatening thromboembolic events because of their disease, individual risk factors, and antimyeloma or…”
Get full text